CCIA
TARO

Campbell & Co Investment Adviser’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Campbell & Co Investment Adviser’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,533
Closed -$473K – 797
2019
Q2 		$473K Buy
+5,533
New +$547K 0.21% 153

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Campbell & Co Investment Adviser's TARO Position: Q3 2019 in Review

Campbell & Co Investment Adviser sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2019, closing a stake of 5,533 shares — an estimated $473K sold.

Campbell & Co Investment Adviser first reported a position in TARO in Q2 2019 and held it in 1 quarter. The position peaked at $473K in Q2 2019. 101 funds tracked by Wall St. Rank hold TARO as of Q3 2019.

  • Campbell & Co Investment Adviser reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2019 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 5,533 Taro Pharmaceutical Industries Ltd. shares in Q3 2019, an estimated $473K.
  • Campbell & Co Investment Adviser first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2019 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's Taro Pharmaceutical Industries Ltd. position peaked at $473K in Q2 2019.
  • 101 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2019.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2019, filed 16 Oct 2019.